Navigation Links
Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave®
Date:9/20/2011

pion HCl, was studied for its ability to help people with obesity initiate and sustain weight loss of at least 5 percent of their starting body weight in one year. Contrave was submitted for U.S. regulatory approval in March 2010. The original submission was based on multiple clinical trials that evaluated Contrave in more than 4500 patients. Orexigen received a Complete Response letter from FDA on January 31, 2011.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave has completed Phase 3 clinical trials, and the Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Each of the components of the Company's product candidates has already received regulatory approval and has been commercialized previously. Further information about the Company can be found at www.orexigen.com.

Forward-Looking Statements Related to Orexigen

Orexigen cautions you that statements included in this press release and the conference call are not a description of historical facts are forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "intends," "potential," "suggests," "assuming," "designed" and similar expressions are intended to identify forward-looking statements. These statements are based on the Company's current beliefs and expectations. These forward-looking statements include statements regarding: the study design for, and the timing and feasibility of, the CVOT; the potential for resubmission and approval of an NDA based on interim results of the CVOT; the prospects for ultimate approval of an NDA for Contrave; and the potential to complete a partnership or similar transaction for ex-North American rights to Contrave and maintain the Company's existing North American collaboration with Takeda Pharmaceuticals. The inclusion of
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results
2. Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA
3. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
4. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
5. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
6. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
7. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
10. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
11. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... PLAINSBORO, N.J. , April 28, 2015 /PRNewswire-USNewswire/ ... treatments but they also require more of manufacturers, ... Times , the specialty pharmacy field,s premiere journal, ... Pharmacy (NASP), the only national trade association dedicated ... pharmacy businesses and clinicians to fill this growing ...
(Date:4/28/2015)... 28, 2015 The pharmacy information ... million by 2019, growing at a CAGR of 7.7% ... TOC of the pharmacy information systems market, to get ... provides a glimpse of the segmentation of pharmacy information ... by various tables and figures. http://www.micromarketmonitor.com/market-report/pharmacy-information-system-reports-2473565504.html ...
(Date:4/28/2015)... MAHWAH, N.J. , April 28, 2015 ... Tour," Stryker Orthopaedics, is kicking off tournament week by ... the second consecutive year appearing at the tournament, Stryker ... fans about the importance of joint health and mobility. ... Woodlands , Stryker is bringing new features to ...
Breaking Medicine Technology:Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 2Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 3Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 4Pharmacy Information Systems Market is Expected to Reach $3,876.3 Million by 2019, at a CAGR of 7.7% From 2014 to 2019 2Pharmacy Information Systems Market is Expected to Reach $3,876.3 Million by 2019, at a CAGR of 7.7% From 2014 to 2019 3The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 2The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 3The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 4
(Date:4/28/2015)... 28, 2015 Aultman Hospital in ... (WCA) to transition its outpatient wound center electronic ... commitment to the specialty of wound care by ... country currently working with Wound Care Advantage ... wound care treatments and hyperbaric oxygen therapy to ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Consolidated ... are moving forward nationwide, as courts overseeing proceedings ... next month. According to court documents issued in ... the next status conference in the federal Xarelto ... 9:00 a.m. C.S.T. (In Re: Xarelto Products ...
(Date:4/28/2015)... Seton Hall University Provost Larry A. Robinson has ... Dean of Seton Hall School of Law. She will begin ... Boozang, currently Associate Dean for Academic Advancement and Professor of ... launch and currently directs the school’s prestigious Center for ... 10 law health program by U.S. News & World Report ...
(Date:4/28/2015)... 2015 April 8th, 2015, saw ... “RockNRolla Movie Awards” EcoLuxe Lounge, with Choices Recovery ... Entertainment, Los Angeles’ leading producer of sustainable product ... force behind this event, which featured some of ... conscious products and services. The EcoLuxe Lounge is ...
(Date:4/28/2015)... April 28, 2015 Children’s Medical ... the cause of medical foods and formulas through ... as the organization’s new executive director. , Thousands ... health consequences because of conditions and diseases that ... diet. To live and thrive, they are ...
Breaking Medicine News(10 mins):Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 2Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 3Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 2Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 3Health News:Choices Recovery South Bend Examines Support Systems in Treatment with Hollywood's Mike Pericoloso 2Health News:Children's Medical Nutrition Alliance (CMNuA) Hires Kaycee Childress as Executive Director 2
... March 23 Master,s and doctoral degree ... Carolina public and private colleges and universities may ... for the 2010-11 academic year at the college information ... for the coming year, according to the North Carolina ...
... teleconference is just as effective as face-to-face sessions, according ... professor at the Universit de Montral. "Previous ... just as efficient as face to face contact," says ... Studies Centre at the Louis-H. Lafontaine Hospital,s Fernand-Seguin Research ...
... protein changes in the blood linked to alcohol use may ... currently available, according to Penn State College of Medicine researchers. ... substance abuse -- things like cocaine or heroin or PCP ... those over 21," said Willard M. Freeman, Ph.D., department of ...
... ... replacement, may be an appropriate first step for many people with knee joint arthritis ... the long-term feasibility of artificial knee replacement. , ... San Francisco, CA (PRWEB) March 22, 2010 -- Biologic ...
... Toys“R”Us, ... in April Activities , ... New York, NY (PRWEB) March 23, 2010 -- Autism Speaks ... awareness and fundraising initiatives involving a range of corporate and philanthropic partners that will ...
... that replacing saturated fats has heart benefits , ... with polyunsaturated fats may reduce your risk of heart ... Health researchers reviewed eight studies with a total of ... fats in their diet with polyunsaturated fats had a ...
Cached Medicine News:Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 2Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 3Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 4Health News:Therapy via teleconference? 2Health News:Proteins may point to alcohol use test 2Health News:Proteins may point to alcohol use test 3Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 2Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 3Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 4Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 5Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 2Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 3Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 4Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 5Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 6Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 7Health News:Polyunsaturated Fats Really May Lower Heart Risk 2
The Shandon Manual Staining Station is ideal for special processes, frozen sections, special stains and low volume procedures....
The Shandon Finesse 315 low-cost precision microtome is ergonomically designed to consistently produce high quality routine paraffin sections without user strain or fatigue....
The new Shandon HistocentreTM 3 is an integral part of the workflow in Histology laboratories, representing a workstation that complements any automatic tissue processor....
Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains....
Medicine Products: